Lilly’s diabetes drug as effective as Sanofi’s in late-stage trials

[Reuters] – Eli Lilly and Co said its type 2 diabetes treatment was as effective as Sanofi SA’s approved drug Lantus in reducing patients’ blood sugar levels in three late-stage trials. Lilly said it expected to file … more

View todays social media effects on LLY

View the latest stocks trending across Twitter. Click to view dashboard

See who Eli is hiring next, click here to view